Mesoblast Limited: Ryoncil FDA Approval and Market Launch Highlighted at Tandem ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...